NCT00082888 2020-04-13Tipifarnib in Treating Patients With Relapsed or Refractory LymphomaNational Cancer Institute (NCI)Phase 2 Completed93 enrolled 12 charts
NCT00360776 2017-04-05Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte LeukemiaNational Cancer Institute (NCI)Phase 2 Terminated25 enrolled
NCT00005967 2013-02-11Tipifarnib in Treating Patients With Advanced Hematologic CancerNational Cancer Institute (NCI)Phase 1 Completed36 enrolled